Shorts

0:39
The Gift of Removing Prior Authorizations
a year ago
by
Peter Lio, MD

0:39
Prior Authorization Denials Lack Transparency
a year ago
by
John Barbieri, MD, MBA, FAAD

0:44
The Key Difference Between Treating Adult and Pediatric Patients
a year ago
by
Patrick Burnett, MD, PhD

0:52
Ethical Dilemmas in Dermatology
a year ago
by
Heather Goff, MD, MPH

0:34
How Dermatologists Should Guide the Future of Artificial Intelligence
a year ago
by
Joseph Gatti, DMSc, MPAS, MBA, PA-C

0:26
Why Social Media is the New WebMD
a year ago
by
Shannon Trotter, DO

0:32
Improving Skin of Color Representation in Training Materials
a year ago
by
Mondana Ghias, MD, FAAD

0:47
The Future of GLP-1 Usage in Dermatology
a year ago
by
Joely Kaufman, MD

0:37
Why Complacency is Devastating in Dermatology
a year ago
by
Rosalyn George, MD

1:30
Derm Dispatch: Live at SDPA Fall 2025
a year ago
by
Renata Block, DMSc, MMS, PA-C

0:13
Breast Cancer Care by Dermatologists: A Year-Round Commitment
a year ago
by
Christopher G. Bunick, MD, PhD

0:34
Leave the Ladder Down: Mentoring the Next Generation
a year ago
by
Lauren Miller, PA-C(+1 more)

0:30
Why Breast Cancer Patients Must Get Routine Skin Exams
a year ago
by
Christopher G. Bunick, MD, PhD

1:00
New Oral Treatments to Revolutionize Psoriasis Care
a year ago
by
Ronald Vender, MD, FRCPC

0:53
From Consultation to Transformation: Emphasizing Strategic Aesthetics at PDPA 2025
a year ago
by
Kachiu C. Lee, M.D.

0:42
Supporting Skin Health in the Prejuvenation Era
a year ago
by
Amy B. Lewis, MD

0:30
What Makes APG777 a Potential First-line Therapy?
a year ago
by
Emma Guttman-Yassky, MD, PhD

0:59
Treating Dermatological Diseases As Processes
a year ago
by
Brian Kim, MD

0:31
Fighting Misinformation on Injectables and HA Fillers
a year ago
by
Lisa Espinoza, MD

0:59
How Dermatologists Can Best Support Patients With BFRBs
a year ago
by
Sofia Wenzler, PhD

1:27
What's the Future of Dosing With ORKA-001?
a year ago
by
Andrew Blauvelt, MD, MBA

1:30
Bridging the Gap Between Patients and Clinical Trials
a year ago
by
Jorge Garcia-Zuazaga, MD, MBA, FAAD, FACMS

0:56
Reviewing Ruxolitinib's Expanded Indication for Pediatric Patients With AD
a year ago
by
Nicole Harter, MD

0:42
Addressing Health Care Bias in Treating Patients of Color
a year ago
by
Buchi Neita, MCMSc, PA-C

0:55
How Deuruxolitinib Blocks Autoimmune Hair Loss in Alopecia Areata
a year ago
by
Vimal Prajapati, MD, FRCPC, DABD

1:30
Essential Recommendations for Dermatologists
a year ago
by
Nayan Patel, PharmD

1:30
Skin Care Trends: Facts vs Misinformation
a year ago
by
Anthony M. Rossi, MD, FAAD, FACMS
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermatology Times Monthly FDA and Pipeline Review: October 2026
2
Updated HS Guidelines Emphasize Biologics and Early Intervention
3
Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year
4
Phase 3 Trial Supports Risankizumab for Pediatric Psoriasis
5
